A number of recent studies on acute leukaemia have focused on pretreatment factors that are of prognostic significance in determining the likelihood of achieving complete remission, remission duration or length of survival. Even so, it has been difficult to identify convincing clinical or haematological criteria for predicting the response to cytostatic drugs. Determination of colony formation has become a useful tool for investigating the abnormal regulation of haematopoiesis. Therefore, several investigators have tried to correlate the in vitro growth pattern of granulopoietic progenitor cells with the prognostic outcome (Keating et al., 1980; Elias & Greenberg, 1977; Moore et al., 1974; Hornsten et al., 1977; Beran et al., 1980; Gustavsson et al., 1981) . However, the results have been conflicting due to poor reproducibility and differences in culture technique, sources of colony stimulating activity, classification of growth pattern, therapeutic regimens, selection of patients, and inadequate statistical analysis. The objective of the present study was (a) to investigate in each patient with acute myelogenous (AML) and lymphocytic leukaemia (ALL), the in vitro colony-forming capacity of both bone marrow and peripheral blood at first diagnosis, during induction treatment, in remission and relapse; and (b) to evaluate the prognostic utility of this in vitro assay in respect of rate of remission, remission duration, and length of survival.
Fifty consecutive, previously untreated adults with acute leukaemia were investigated over a 2yr-period; 31 were cases of AML and 19 were of ALL. The morphological and immunological variants as well as clinical details are summarized in Table I . Bone marrow was evaluated 15-21 days after the end of each cycle. Two-4 courses were given, including one course of consolidation for patients who achieved complete remission. Treatment was discontinued after the 3rd cycle in patients who failed to respond. For maintenance, the majority of patients received oral thioguanin (70mgm-2) on 4 consecutive days and cytosine arabinoside subcutaneously (80mgm-2) on the 5th day, weekly till relapse.
Initial The growth pattern of the peripheral blood was contrary to that of the bone marrow: the number of colonies continuously decreased and, after 3-4 months were found only sporadically. At first diagnosis, marrow clusters in AML and ALL were within normal range, and clusters from the peripheral blood were significantly above normal controls. At remission, the number of clusters in the bone marrow was significantly lower than before therapy. In contrast to colony-growth, bone marrow cluster in AML and ALL showed an overshoot 3-4 months after remission occurred and remained at normal levels during remission. Clusters disappeared from the peripheral blood, although 3-4 months later than colonies. The in vitro growth pattern of both colonies and clusters in marrow and blood during relapse was similar to that at first diagnosis.
AML-patients responding to therapy showed (Figure 1 ) less colony-growth and significantly less cluster-growth in bone marrow and displayed more frequent negative cultures than those failing to respond. In contrast, blood cultures ( Figure 2 ) had significantly more colonies and clusters in the responder than non-responder group, the latter containing significantly more negative cultures. In other words, poor in vitro growth in the bone marrow and normal or high numbers of CFUC in the peripheral blood, ensured for AML patients a good chance of reaching complete remission. Comparison of remission incidence in marrow and blood of ALL-patie.its showed that the growth pattern was opposite to that of patients with AML: more colony and cluster growth in the bone marrow and normal growth in the peripheral blood in patients responding to therapy than in the nonresponder group.
In good agreement with this is the observation that patients with AML can be expected to have significantly longer remission (P<0.02) when high numbers of clusters and colonies are found in the peripheral blood, before therapy is initiated. No such correlation existed for patients with ALL prior to induction therapy. At relapse, however, patients showing many clusters and/or colonies in the marrow, had significantly longer remissions (P = 0.03/0.01) than those with poor bone marrow growth. The pretreatment growth-characteristics were not of predictive significance for survival in either AML or Al L.
The degree of marrow infiltration with blast cells was not of prognostic value. In AML, the mean values were 65% blasts in the therapy-responsive compared with 54% in the non-responsive group.
The corresponding figures for ALL patients were 72% and 73%. However in ALL, high blast cell counts in the bt ne ma-row correlated significantly with many clusters in the peripheral blood, indicating a blast cell-dependent mechanism for emigration of normal progenitor cells from marrow into the peripher? blood.
There is strong evidence that clusters and colonies growing an-er the culture conditions used in this study, are derived from normal residual stem cells (Metcalf & Moore, 1971; Pike & Robinson, 1970) and not from leukaemic cells (Hoelzer et al., 1977) . Even so, there seems no simple way of determining the origin of colonies and clusters. In a recent study (Marie et al., 1981) , evidence was presented that in AML a minority of clusters are formed from blast cells and some granulopoietic differentiation may be expressed during blast colony formation even though morphological evidence of differentiation is not apparent. We conclude from the overshooting reappearance of clusters in the bone marrow 1-2 months after haematological remission had been reached and from the continuous disappearance in the peripheral blood during remission, that the clusters seen in our experiments represent normal granulopoietic progenitor cells. Our observation that clusters found in the bone marrow of both leukaemias during remission were far above normal while bone marrow colonies never return to normal levels, is in good agreement with the finding (Broxmeyer et al., 1979) of persistent inhibitory activity against the formation of granulocyte and macrophage colonies in cultures of normal bone marrow cells during remission of acute leukaemia.
All patients followed during induction treatment showed some reduction in colony-forming ability, regardless of whether they reached complete remission or not. The lowest values were found when patients had recovered from leukopenia and remission was first diagnosed. This suggests that cytotoxic drugs affect CFUC with some latency (Necas et al., 1979; Francis et al., 1981) . Colonyforming capacity reappeared fully -1 month after remission was attained. A second nadir occurred in association with the antecedent consolidation cycle.
The divergent pattern of blood and marrow culture growth in our patients with AML and ALL (clu) (Beran et al., 1980) , AML patients showing an increased number of clones in marrow cultures responded poorly to therapy, but those with a decreased clone number, predominantly clusters, and a high percentage of negative leukaemias achieved significantly more frequent complete remission. In the circulating blood, the situation was opposite to that in bone marrow viz. high numbers of colony and clusters forming cells and less negative cultures in the good prognosis group. This relation between a favourable prognosis in terms of remission incidence and the presence of colony-forming cells in the peripheral blood has been noticed earlier (Hornsten et al., 1977) . Furthermore, longer remissions were much more frequent among AMLpatients whose blood cells showed many colonies and clusters. In a multivariant analysis of several pretreatment factors, Keating et al. (1980) found a similar significant correlation between high numbers of clusters and long remission. Since on the other hand, our non-responding group has less colonies and clusters in the peripheral blood than responders, one possible explanation of our results is that in AML the remaining normal haematopoiesis of those leukaemias which can respond to therapy deserts the homing bone marrow and migrates into the peripheral blood. According to our results such a mechanism would 105- be independent of the degree of blast infiltration. In the poor prognosis group, such an escape of normal granulopoiesis does not occur and would be ultimately rejected.
In the ALL-group, although small in size, the results differed markedly from those found in AMLpatients. The in vitro growth of blood clusters and colonies remained within nor lal limits, equally in responsive and non-responsive patients. For ALLpatients prior to any therapy, there was a definite trend (although insignifican.) toward achieving remission and obtaining long remissions when high CFUC counts were found in the marrow culture. Both correlations were significant at relapse. Cell surface characteristics have uncovered a variety of ALL-subgroups with close correlation to the prognosis of the disease (Greaves et al., 1978) . At first diagnosis we found 6 different types, but at relapse only 2 remained. This might explain the slight discrepancies in significance between the time of first presentation and relapse. In ALL, no emigration phenomenon with prognostic relevance could be observed. However, there was a significant correlation between blast infiltration of the marrow and the number of clusters in the peripheral blood in that, high numbers of blast cells in the bone marrow implicated high in vitro growth of peripheral blood.
Although much of the information obtained relies upon group analysis the conclusion is that, particularly in AML, and to a minor degree in ALL, the in vitro growth pattern at diagnosis is a prognostic indicator of whether or not patients will respond to chemotherapy and experience long remissions. A good prognosis in terms of remission rate and duration does not necessarily imply a long survival.
